Accuracy of information on printed over-the-counter drug advertisements

Health Marketing Quarterly

Volumn 17, Issue 2, 1999, Pages 7-18

  Sansgiry, Shubhada ^a   Sharp, William T ^a   Sansgiry, Sujit S ^b  

^a IDAHO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Advertising; Consumer behavior; Medications; Over the counter drugs; Regulations

Indexed keywords

NON PRESCRIPTION DRUG;

ADVERTIZING; ARTICLE; DRUG INDUSTRY; DRUG INFORMATION; HUMAN; INTERPERSONAL COMMUNICATION; PATIENT PARTICIPATION; QUALITY CONTROL; SELF MEDICATION; STANDARD; UNITED STATES;

ADVERTISING; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUGS, NON-PRESCRIPTION; HUMANS; PATIENT PARTICIPATION; QUALITY CONTROL; SELF MEDICATION; TRUTH DISCLOSURE; UNITED STATES;

EID: 0033287165     PISSN: 07359683     EISSN: 15450864     Source Type: Journal    
DOI: 10.1300/J026v17n02_02     Document Type: Article

References (14)

1. Anonymous (1984), “CBS consumer study finds need for drug information,” American Pharmacy, 24:5, 12.
2. Gannon K. (1989), “What OTCs do you recommend?” Drug Topics, 133 (15): 42-44, 48, 50.
3. Guerard C. (1985), “The impact advertising and its regulation-A Federal Trade Commission perspective,” Drug Information Journal, 19:163-172.
4. Hoff L. C. (1975), “How often do consumers seek your advice on Rx and OTC products,” Pharmacy Times, August: 52-55.
5. Newton G., Popovich N.G., and Pray S.W. (1996), “Rx-to-OTC switches: From prescription to self-care,” Journal of American Pharmaceutical Association, NS36: 488-495.
6. NDMA (1993), Nonprescription Drug Manufacturers Association. “Leading 25 OTC Drug Brands,” Washington DC: NDMA.
7. Pathak D.S., Escovitz A., and Kucukarslan S. (1992), “Pharmaceutical promotion: Information or persuasion?” Journal of Pharmaceutical Marketing and Management, 7 (1): 1-4.
8. Patil Shubhada (1995), “Evaluation and interpretation of printed over-the-counter drug advertisements” [Thesis], Pocatello, ID: Idaho State University.
9. Peeler L.C. (1992), “Pharmaceutical advertising: A Federal Trade Commission perspective,” In: Promotion of pharmaceuticals: Issues, trends, options. The Ha-worth Press, Inc.
10. Popovich N.G, Newton G.D., and Pray S.W. (1992), “New OTC drugs: A selected review,” American Pharmacy, NS32 (2): 26-38.
11. Rheinstein P.H. and Mazis M.B. (1976), “Regulation of OTC Drug Advertising: The FDA Prescription,” Journal of American Pharmaceutical Association, NS16 (9): 505-506, 524-525.
12. Sansgiry S.S., Cady P.S., and Patil S. (1997), “Readability of over-the-counter medication labels,” Journal of American Pharmaceutical Association, NS37 (5): 522-528.
13. Wilkes W.L. (1992), Advertising influences on consumer behavior: Consumer behavior. Wiley and Sons, Inc.
14. Wilkes M.S., Doblin B.H., and Shapiro M.F. (1992), “Pharmaceutical advertisements in leading medical journals: Expert’s assessments,” Annals of Internal Medicine, 116: 912-919.